Acetylkitamycin

乙酰吉他霉素

Report date: 2025/07/17 10:38:26
NME

Base Information

Drug NameAcetylkitamycin
Drug Alias Name柱晶白霉素Acetyl Kitasamycin
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChongqing Daxin Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChongqing Daxin Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01
Related LinksKEGG